ARDX Ardelyx Inc
- Stocks
- Healthcare
- NASDAQ: ARDX
Price (delayed)
$5.95
Market cap
$1.45B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.23
Enterprise value
$1.61B
Relative Growth:
Rel. Growth:
74
Relative Strength:
Rel. Strength:
73
Relative Valuation:
Rel. Valuation:
15
Relative Profitability:
Rel. Profitability:
40
Ardelyx is focused on discovering, developing, and commercializing innovative first-in-class medicines to enhance the lives of patients with kidney and cardiorenal diseases. Ardelyx is advancing tenapanor, a novel product candidate
Highlights
The company's gross profit has surged by 64% YoY and by 7% QoQ
The company's revenue has surged by 58% YoY and by 3.1% QoQ
Ardelyx's equity has increased by 11% QoQ but it has decreased by 2.5% YoY
Ardelyx's debt has surged by 99% YoY
Key stats
What are the main financial stats of ARDX
Market
Valuations
Earnings
Shares outstanding
242.97M
Market cap
$1.45B
Enterprise value
$1.61B
Price to earnings (P/E)
N/A
Price to book (P/B)
9.29
Price to sales (P/S)
3.61
PEG
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.04
Revenue
$398.23M
Gross profit
$351.28M
Operating income
-$37.95M
Net income
-$56.55M
EBIT
-$37.24M
EBITDA
-$31.96M
Free cash flow
-$55.35M
Per share
Balance sheet
Liquidity
EPS
-$0.23
EPS diluted
-$0.23
Free cash flow per share
-$0.23
Book value per share
$0.64
Revenue per share
$1.65
TBVPS
$2.01
Total assets
$486.17M
Total liabilities
$331.89M
Debt
$207.61M
Equity
$154.28M
Working capital
$284.6M
Debt to equity
1.35
Current ratio
4.41
Quick ratio
3.83
Net debt/EBITDA
-5.16
Margins
Efficiency
Dividend
EBITDA margin
-8%
Gross margin
88.2%
Net margin
-14.2%
Operating margin
-9.5%
Return on assets
-12.6%
Return on equity
-36.9%
Return on invested capital
-7.5%
Return on capital employed
-9.2%
Return on sales
-9.4%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ARDX stock price
How has the Ardelyx stock price performed over time
Intraday
6.25%
1 week
19.96%
1 month
13.12%
1 year
4.02%
YTD
17.36%
QTD
7.99%
Financial performance
How have Ardelyx's revenue and profit performed over time
Revenue
$398.23M
Gross profit
$351.28M
Operating income
-$37.95M
Net income
-$56.55M
Gross margin
88.2%
Net margin
-14.2%
The company's gross profit has surged by 64% YoY and by 7% QoQ
ARDX's operating margin has surged by 63% year-on-year and by 10% since the previous quarter
The company's revenue has surged by 58% YoY and by 3.1% QoQ
Ardelyx's net margin has surged by 51% YoY and by 2.7% QoQ
Price vs fundamentals
How does ARDX's price correlate with its fundamentals
Growth
What is Ardelyx's growth rate over time
Valuation
What is Ardelyx stock price valuation
P/E
N/A
P/B
9.29
P/S
3.61
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.04
The EPS has increased by 26% year-on-year
ARDX's P/B is 52% above its 5-year quarterly average of 6.1 and 22% above its last 4 quarters average of 7.6
Ardelyx's equity has increased by 11% QoQ but it has decreased by 2.5% YoY
The price to sales (P/S) is 81% lower than the 5-year quarterly average of 18.7 but 13% higher than the last 4 quarters average of 3.2
The company's revenue has surged by 58% YoY and by 3.1% QoQ
Efficiency
How efficient is Ardelyx business performance
The return on sales has surged by 61% year-on-year and by 8% since the previous quarter
The company's return on invested capital has surged by 59% YoY and by 17% QoQ
Ardelyx's ROA has increased by 41% YoY and by 6% from the previous quarter
Ardelyx's ROE has increased by 21% YoY
Dividends
What is ARDX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ARDX.
Financial health
How did Ardelyx financials performed over time
ARDX's total assets is 46% greater than its total liabilities
ARDX's total liabilities has surged by 58% year-on-year
ARDX's total assets is up by 32% year-on-year and by 4.2% since the previous quarter
Ardelyx's debt is 35% higher than its equity
Ardelyx's debt to equity has surged by 105% YoY but it has decreased by 9% QoQ
Ardelyx's debt has surged by 99% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.